Rosen Law Firm is investigating a class action lawsuit against TruBridge, Inc. after the company disclosed errors in its financial statements for 2023 and 2024, leading to a delayed annual report and a 10.5% drop in its stock price. The errors involved revenue recognition, contract costs, stock-based compensation, and software development expenses. Investors who bought TruBridge securities may seek compensation through this class action without upfront fees. The firm encourages affected shareholders to join the lawsuit to recover losses.
Jefferies downgraded Home Depot from Buy to Hold due to worries over minimal profit growth despite expected revenue rise in Q2. Customer transactions have declined for five quarters, indicating growth relies on bigger purchases, not more customers. M...
Historical data suggests that a $10,000 investment in the QQQ ETF could increase to approximately $66,000 over a decade. This highlights the potential long-term growth of technology-focused investments. Investors might consider this when planning the...
NeuroThera Labs Inc., a clinical-stage biotech company, has closed the final tranche of its non-brokered private placement, raising C$2.7 million by selling 22.5 million units at C$0.12 each. Each unit includes one common share and one warrant exerci...
Fabrinet reported quarterly earnings with an EPS of $4.10 and revenue of $1.32 billion, exceeding analyst expectations and marking a 45% increase in revenue year-over-year. The company specializes in optical packaging and manufacturing for high-growt...
Polygon Labs has entered Phase 2 of the Bank of England's Digital Pound Lab, collaborating with NOBO Finance and Dun & Bradstreet to explore near-instant cross-border settlements and portable credit identities using Polygon's Open Money Stack technol...
